Sang-A Park

EW-7197 inhibits hepatic, renal, and pulmonary fibrosis by blocking TGF-β/Smad and ROS signaling

Jeong-Seok Nam, So-Yeon Park, Y. Sheen, 2014, Cellular and Molecular Life Sciences.

Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells

Jeong-Seok Nam, W. Lim, So-Yeon Park, 2015, Oncotarget.

EW-7197, a Novel ALK-5 Kinase Inhibitor, Potently Inhibits Breast to Lung Metastasis

Jeong-Seok Nam, So-Yeon Park, Sol-Ji Kim, 2014, Molecular Cancer Therapeutics.

Targeting the Transforming Growth Factor-β Signaling in Cancer Therapy

Jeong-Seok Nam, So-Yeon Park, Y. Sheen, 2013, Biomolecules & therapeutics.

EW-7197 inhibits hepatic, renal, and pulmonary fibrosis by blocking TGF-β/Smad and ROS signaling

Jeong-Seok Nam, Y. Sheen, H. Woo, 2015, Cellular and Molecular Life Sciences.

TIMP-1 mediates TGF-β-dependent crosstalk between hepatic stellate and cancer cells via FAK signaling

Jeong-Seok Nam, W. Lim, Sodam Park, 2015, Scientific Reports.

TGF-β Type I Receptor Kinase Inhibitor EW-7197 Suppresses Cholestatic Liver Fibrosis by Inhibiting HIF1α-Induced Epithelial Mesenchymal Transition

Jeong-Seok Nam, So-Yeon Park, Y. Sheen, 2016, Cellular Physiology and Biochemistry.

EW-7197, a Novel ALK-5 Kinase Inhibitor, Potently Inhibits Breast to Lung Metastasis

Jeong-Seok Nam, So-Yeon Park, Sol-Ji Kim, 2014, Molecular Cancer Therapeutics.